查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504997

非侵入性产前检查市场，占有率，规模，趋势，产业分析报告:各妊娠期间，各组成类别，各方法，各用途，各最终用途，各地区，各市场区隔预测，2024年～2032年

Non-Invasive Prenatal Testing Market Share, Size, Trends, Industry Analysis Report, By Gestation Period; By Component; By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球无创产前检测 (NIPT) 市场规模预计将达到 101 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于遗传疾病发生率的增加、早期胎儿检测意识的提高以及孕产妇年龄的增加，预计在预测期内，非侵入性产前检测的市场需求将会增加。医疗基础设施市场的显着成长、技术进步和有利的监管是预计在预测期内提供成长机会的一些因素。

孕龄段分为0-12週、13-24週、25-36週。在第 13 週至第 24 週之间进行的检查包括血液检查和超音波检查，以检测遗传性疾病或神经管缺陷。此时也进行超音波检查以检查解剖结构和相关疾病。无创产前检测所需的耗材需求量大。人们对胎儿检测的认识不断提高，加上技术进步、支持性政府法规和先进的医疗基础设施正在推动市场成长。

非侵入性产前检测用于检测单体、三体、微缺失症候群等。由于三体检测的准确性高、母亲年龄的增加以及人们对早期和非侵入性胎儿诊断的认识不断提高，三体在全球无创产前检测市场中占有重要占有率。三体性检测测试从第 10 週开始进行，以提高检测三种常见三体性（包括 21、18 和 13 号染色体）的安全性、可靠性和准确性。

各种非侵入性产前检测方法包括母体血浆中的游离 DNA 检测、超音波检测和生化筛检检测。预计母体血浆中的无细胞 DNA 片段在预测期内将显着增长。透过这种方法提高染色体异常检测的准确性、提高患者意识以及有效规划妊娠管理是推动该细分市场成长的因素。

诊断中心、医院、诊所等提供非侵入性产前检测服务。 2020年诊断中心产业占比最高。染色体异常发生率的增加和政府的支持措施正在支持该细分市场的成长。专业设备、先进的医疗基础设施和专家的存在进一步鼓励患者前往诊断中心就诊。

北美在 2020 年主导全球 NIPT 市场，预计在预测期内将保持其主导地位。高生活水平、对医疗保健服务的大量投资以及染色体异常发生率的增加正在支持该地区的市场成长。然而，亚太地区预计在预测期内将出现显着成长。人口增长和胎儿检测意识的提高正在推动该地区的成长。世界领先的公司正在中国、日本、印度和韩国等发展中国家扩大业务，以利用这些国家提供的成长机会。

由于技术的进步和满足客户需求的日益增长，各公司正在共同努力加强其在市场上的影响力并获得市场占有率。扩大产品组合是该行业的另一个趋势。

主要市场参与者包括 Agilent Technologies, Inc.、Laboratory Corporation of America Holdings、Illumina, Inc.、F. Hoffman-La Roche Ltd.、Yourgene Health、Perkinelmer, Inc.、GE Healthcare、Quest Diagnostics、Thermo Fisher Scientific, Inc.、Sequenom、Qiagen NV、Koninklijke Philips NV、Natera, Inc.、北京华大基因研究所和Pacific Biosciences of California, Inc.

第一章目录

第2章 简介

第3章 执行概要

第4章 调查手法

第5章 非侵入性产前检查市场洞察

  • 非侵入性产前检查-产业概要
  • 非侵入性产前检查市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 大环境分析
  • 非侵入性产前检查市场产业趋势

第6章 各妊娠期间的非侵入性产前检查市场评估

  • 主要调查结果
  • 简介
    • 全球非侵入性产前检查市场，各妊娠期间，2016～2028年
  • 0～12週
    • 全球非侵入性产前检查市场，0～12週各，各地区，2016～2028年
  • 13～24週
    • 全球非侵入性产前检查市场，13～24週各，各地区，2016～2028年
  • 25～36週
    • 全球非侵入性产前检查市场，25～36週各，各地区，2016～2028年

第7章 全球非侵入性产前检查市场:各组成类别

  • 主要调查结果
  • 简介
  • 消耗品
  • 设备
  • 软体
  • 服务

第八章全球非侵入性产前检测市场：依应用划分

  • 主要调查结果
  • 简介
  • 单体性
  • 三体性
  • 微缺失症候群
  • 其他

第9章 各方法的非侵入性产前检查市场评估

  • 主要调查结果
  • 简介
    • 全球非侵入性产前检查市场，各方法，2016～2028年
  • 母体血浆检验的脱离DNA
    • 全球非侵入性产前检查市场，母体血浆检验的细胞脱离DNA，各地区，2016～2028年
  • 超音波检测
    • 全球非侵入性产前检查市场，超音波检测，各地区，2016～2028年
  • 生物化学筛检检验
    • 全球非侵入性产前检查市场，生物化学筛检检查别，各地区，2016～2028年
  • 其他
    • 全球非侵入性产前检查市场，其他，各地区，2016～2028年

第10章 全球非侵入性产前检查市场:各最终用途

  • 主要调查结果
  • 简介
  • 诊断中心
  • 医院
  • 诊所
  • 其他

第11章 各地区的非侵入性产前检查市场评估

  • 主要调查结果
  • 简介
    • 非侵入性产前检查市场评估:地区，2016～2028年
  • 北美
    • 北美:各妊娠期间，2016～2028年
    • 北美:各组成类别，2016～2028年
    • 北美:各用途，2016～2028年
    • 北美:各方法，2016～2028年
    • 北美:各最终用途，2016～2028年
    • 美国
      • 美国:各妊娠期间，2016～2028年
      • 美国:各组成类别，2016～2028年
      • 美国:各用途，2016～2028年
      • 美国:各方法，2016～2028年
      • 美国:各最终用途，2016～2028年
    • 加拿大
      • 加拿大:各妊娠期间，2016～2028年
      • 加拿大:各组成类别，2016～2028年
      • 加拿大:申请，2016～2028年
      • 加拿大:各方法，2016～2028年
      • 加拿大:各最终用途，2016～2028年
  • 欧洲
    • 欧洲:各妊娠期间，2016～2028年
    • 欧洲:各组成类别，2016～2028年
    • 欧洲:各用途，2016～2028年
    • 欧洲:各方法，2016～2028年
    • 欧洲:各最终用途，2016～2028年
    • 英国
      • 英国:各妊娠期间，2016～2028年
      • 英国:各组成类别，2016～2028年
      • 英国:各用途，2016～2028年
      • 英国:各方法，2016～2028年
      • 英国:各最终用途，2016～2028年
    • 法国
      • 法国:各妊娠期间，2016～2028年
      • 法国:各组成类别，2016～2028年
      • 法国:各用途，2016～2028年
      • 法国:各方法，2016～2028年
      • 法国:各最终用途，2016～2028年
    • 德国
      • 德国:各妊娠期间，2016～2028年
      • 德国:各组成类别，2016～2028年
      • 德国:各用途，2016～2028年
      • 德国:各方法，2016～2028年
      • 德国:各最终用途，2016～2028年
    • 义大利
      • 义大利:各妊娠期间，2016～2028年
      • 义大利:各组成类别，2016～2028年
      • 义大利:各用途，2016～2028年
      • 义大利:各方法，2016～2028年
      • 义大利:各最终用途，2016～2028年
    • 西班牙
      • 西班牙:各妊娠期间，2016～2028年
      • 西班牙:各组成类别，2016～2028年
      • 西班牙:各用途，2016～2028年
      • 西班牙:各方法，2016～2028年
      • 西班牙:各最终用途，2016～2028年
    • 其他的欧洲
      • 其他的欧洲:各妊娠期间，2016～2028年
      • 其他的欧洲:各组成类别，2016～2028年
      • 其他的欧洲:各用途，2016～2028年
      • 其他的欧洲:各方法，2016～2028年
      • 其他的欧洲:各最终用途，2016～2028年
  • 亚太地区
    • 亚太地区:各妊娠期间，2016～2028年
    • 亚太地区:各组成类别，2016～2028年
    • 亚太地区:各用途，2016～2028年
    • 亚太地区:各方法，2016～2028年
    • 亚太地区:各最终用途，2016～2028年
    • 中国
      • 中国:各妊娠期间，2016～2028年
      • 中国:各组成类别，2016～2028年
      • 中国:各用途，2016～2028年
      • 中国:各方法，2016～2028年
      • 中国:各最终用途，2016～2028年
    • 印度
      • 印度:各妊娠期间，2016～2028年
      • 印度:各组成类别，2016～2028年
      • 印度:各用途，2016～2028年
      • 印度:各方法，2016～2028年
      • 印度:各最终用途，2016～2028年
    • 韩国
      • 韩国:各妊娠期间，2016～2028年
      • 韩国:各组成类别，2016～2028年
      • 韩国:各用途，2016～2028年
      • 韩国:各方法，2016～2028年
      • 韩国:各最终用途，2016～2028年
    • 日本
      • 日本:各妊娠期间，2016～2028年
      • 日本:各组成类别，2016～2028年
      • 日本:各用途，2016～2028年
      • 日本:各方法，2016～2028年
      • 日本:各最终用途，2016～2028年
    • 亚太地区
      • Ro亚太地区:各妊娠期间，2016～2028年
      • Ro亚太地区:各组成类别，2016～2028年
      • Ro亚太地区:各用途，2016～2028年
      • Ro亚太地区:各方法，2016～2028年
      • Ro亚太地区:各最终用途，2016～2028年
  • 中东·非洲
    • 中东·非洲:各妊娠期间，2016～2028年
    • 中东·非洲:各组成类别，2016～2028年
    • 中东·非洲:各用途，2016～2028年
    • 中东·非洲:各方法，2016～2028年
    • 中东·非洲:各最终用途，2016～2028年
    • 沙乌地阿拉伯
      • 沙乌地阿拉伯:各妊娠期间，2016～2028年
      • 沙乌地阿拉伯:各组成类别，2016～2028年
      • 沙乌地阿拉伯:各用途，2016～2028年
      • 沙乌地阿拉伯:各方法，2016～2028年
      • 沙乌地阿拉伯:各最终用途，2016～2028年
    • 阿拉伯联合大公国
      • 阿拉伯联合大公国:各妊娠期间，2016～2028年
      • 阿拉伯联合大公国:各组成类别，2016～2028年
      • 阿拉伯联合大公国:各用途，2016～2028年
      • 阿拉伯联合大公国:各方法，2016～2028年
      • 阿拉伯联合大公国:各最终用途，2016～2028年
    • 以色列
      • 以色列:各妊娠期间，2016～2028年
      • 以色列:各组成类别，2016～2028年
      • 以色列:各用途，2016～2028年
      • 以色列:各方法，2016～2028年
      • 以色列:各最终用途，2016～2028年
    • 南非
      • 南非:各妊娠期间，2016～2028年
      • 南非:各组成类别，2016～2028年
      • 南非:各用途，2016～2028年
      • 南非:各方法，2016～2028年
      • 南非:各最终用途，2016～2028年
    • 其他的中东·非洲
      • 其他的中东·非洲:各妊娠期间，2016～2028年
      • 其他的中东·非洲:各组成类别，2016～2028年
      • 其他的中东·非洲:各用途，2016～2028年
      • 其他的中东·非洲:各方法，2016～2028年
      • 其他的中东·非洲:各最终用途，2016～2028年
  • 南美
    • 南美:各妊娠期间，2016～2028年
    • 南美:各组成类别，2016～2028年
    • 南美:各用途，2016～2028年
    • 南美:各方法，2016～2028年
    • 南美:各最终用途，2016～2028年
    • 墨西哥
      • 墨西哥:各妊娠期间，2016～2028年
      • 墨西哥:各组成类别，2016～2028年
      • 墨西哥:各用途，2016～2028年
      • 墨西哥:各方法，2016～2028年
      • 墨西哥:各最终用途，2016～2028年
    • 巴西
      • 巴西:各妊娠期间，2016～2028年
      • 巴西:各组成类别，2016～2028年
      • 巴西:各用途，2016～2028年
      • 巴西:各方法，2016～2028年
      • 巴西:各最终用途，2016～2028年
    • 哥伦比亚
      • 哥伦比亚:各妊娠期间，2016～2028年
      • 哥伦比亚:各组成类别，2016～2028年
      • 哥伦比亚:各用途，2016～2028年
      • 哥伦比亚:各方法，2016～2028年
      • 哥伦比亚:各最终用途，2016～2028年
    • 其他的南美
      • 其他的南美:各妊娠期间，2016～2028年
      • 其他的南美:各组成类别，2016～2028年
      • 其他的南美:各用途，2016～2028年
      • 其他的南美:各方法，2016～2028年
      • 其他的南美:各最终用途，2016～2028年

第12章 竞争情形

  • 扩大和收购的分析
    • 扩大
  • 联盟/合作/协定/公开

第13章 企业简介

  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • Yourgene Health
  • Perkinelmer, Inc.
  • GE Healthcare
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Sequenom
Product Code: PM1836

The global non-invasive prenatal testing (NIPT) market size is expected to reach USD 10.10 billion by 2032 according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks); By Component (Consumables, Instruments, Software, Services); By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market demand for non-invasive prenatal testing is expected to increase during the forecast period owing to growth in the occurrence of genetic disorders, increasing awareness regarding early fetal testing, and advancing maternal age. The significant market growth in healthcare infrastructure, technological advancements, and favorable regulations are some factors expected to provide growth opportunities during the forecast period.

The gestation period segment has been divided into 0-12 weeks, 13-24 weeks, 25-36 weeks. Testing performed for 13 - 24 weeks involves blood tests and ultrasound to detect genetic disorders and neural tube defects. Ultrasounds are also used in this period to examine the anatomy and associated disorders. There has been a high demand for consumables required during non-invasive prenatal testing. The rising awareness regarding fetal testing, coupled with technological advancements, supportive government regulations, and advanced healthcare infrastructure boosts the market growth.

Non-invasive prenatal testing is used for the detection of Monosomy, Trisomy, Microdeletion Syndrome, and Others. The trisomy accounted for a major share of the global market for non-invasive prenatal testing owing to high accuracy in detection of trisomy, growing maternal age, and increasing awareness regarding early and non-invasive fetal diagnosis. The test for detection of trisomy is performed after 10 weeks for enhanced safety, reliability, and accuracy for detection of the three common trisomy including chromosomes 21, 18, and 13.

The different methods of non-invasive prenatal testing include cell-free DNA in maternal plasma tests, ultrasound detection, biochemical screening tests, and others. The cell-free DNA in the maternal plasma segment is expected to grow significantly during the forecast period. The increasing accuracy in the detection of chromosomal abnormalities through this method, growing patient awareness, and efficient planning for pregnancy management are some factors driving the growth of this segment.

Non-invasive prenatal testing services are offered in diagnostic centers, hospitals, clinics, and others. The diagnostic centers segment accounted for the highest share in 2020. The increasing occurrence of chromosomal abnormalities coupled with supportive government initiatives supports the growth of this segment. The presence of specialized equipment, advanced healthcare infrastructure, and expert professionals further encourage patients to visit diagnostic centers.

North America dominated the global NIPT market in 2020 and is expected to maintain its dominance over the forecast period. High living standards, significant investment in healthcare services, and increasing occurrence of chromosome abnormalities support market growth in this region. However, Asia-Pacific is expected to exhibit significant growth during the forecast period. Increasing population coupled with increasing awareness regarding fetal testing fuels growth in this region. Leading global players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.

On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain market share. Broadening of the product portfolio is another trend that is visible in the industry.

Some of the major market participants include Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., GE Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Inc., Sequenom, Qiagen N.V., Koninklijke Philips N.V., Natera, Inc., Beijing Genomics Institute, and Pacific Biosciences of California, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing (NIPT) market report on the basis of gestation period, component, method, application, end-use, and region:

Non-Invasive Prenatal Testing (NIPT) Gestation Period Outlook (Revenue, USD Million, 2016 - 2028)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

Non-Invasive Prenatal Testing (NIPT) Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Consumables
  • Instruments
  • Software
  • Services

Non-Invasive Prenatal Testing (NIPT) Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

Non-Invasive Prenatal Testing (NIPT) Method Outlook (Revenue, USD Million, 2016 - 2028)

  • Cell-Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Others

Non-Invasive Prenatal Testing (NIPT) End-Use Outlook (Revenue, USD Million, 2016 - 2028)

  • Diagnostic Centers
  • Hospitals
  • Clinics
  • Others

Non-Invasive Prenatal Testing (NIPT) Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA

1. Table of Contents

2. Introduction

  • 2.1. Report Description
    • 2.1.1. Objectives of the Study
    • 2.1.2. Market Scope
    • 2.1.3. Assumptions
  • 2.2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Non-Invasive Prenatal Testing (NIPT) Market Insights

  • 5.1. Non-Invasive Prenatal Testing (NIPT) - Industry snapshot
  • 5.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
    • 5.2.1. Drivers and Opportunities
    • 5.2.2. Restraints and Challenges
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining Power of Suppliers (Moderate)
    • 5.3.2. Threats of New Entrants: (Low)
    • 5.3.3. Bargaining Power of Buyers (Moderate)
    • 5.3.4. Threat of Substitute (Moderate)
    • 5.3.5. Rivalry among existing firms (High)
  • 5.4. PESTLE Analysis
  • 5.5. Non-Invasive Prenatal Testing (NIPT) Market Industry trends

6. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Gestation Period

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • 6.3. 0-12 weeks
    • 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2016 - 2028 (USD Million
  • 6.4. 13-24 weeks
    • 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2016 - 2028 (USD Million)
  • 6.5. 25-36 weeks
    • 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2016 - 2028 (USD Million)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • 7.3. Consumables
    • 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, By Region, 2016 - 2028 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2016 - 2028 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2016 - 2028 (USD Million)
  • 7.6. Services
    • 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2016 - 2028 (USD Million)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • 8.3. Monosomy
    • 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, By Region, 2016 - 2028 (USD Million)
  • 8.4. Trisomy
    • 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2016 - 2028 (USD Million)
  • 8.5. Microdeletion Syndrome
    • 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2016 - 2028 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other Applications, by Region, 2016 - 2028 (USD Million)

9. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Method

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • 9.3. Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2016 - 2028 (USD Million)
  • 9.4. Ultrasound Detection
    • 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2016 - 2028 (USD Million)
  • 9.5. Biochemical Screening Tests
    • 9.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2016 - 2028 (USD Million)
  • 9.6. Others
    • 9.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2016 - 2028 (USD Million)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 10.3. Diagnostic Centers
    • 10.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, By Region, 2016 - 2028 (USD Million)
  • 10.4. Hospitals
    • 10.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals, by Region, 2016 - 2028 (USD Million)
  • 10.5. Clinics
    • 10.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Clinics, by Region, 2016 - 2028 (USD Million)
  • 10.6. Others
    • 10.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other End-Uses, by Region, 2016 - 2028 (USD Million)

11. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 11.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
    • 11.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.6. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
      • 11.3.6.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.6.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.6.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.6.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.6.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.7. Non-Invasive Prenatal Testing (NIPT) Market - Canada
      • 11.3.7.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.7.2. Canada.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.7.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.7.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.7.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
    • 11.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
      • 11.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
      • 11.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
      • 11.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
      • 11.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
      • 11.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.11. Non-Invasive Prenatal Testing (NIPT) Market - RoE
      • 11.4.11.1. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.11.2. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.11.3. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.11.4. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.11.5. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia-Pacific
    • 11.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
      • 11.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
      • 11.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.8. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
      • 11.5.8.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.8.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.8.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.8.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.8.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
      • 11.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.10. Non-Invasive Prenatal Testing (NIPT) Market - RoAPAC
      • 11.5.10.1. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.10.2. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.10.3. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.10.4. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.10.5. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
      • 11.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
      • 11.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
      • 11.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
      • 11.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.10. Non-Invasive Prenatal Testing (NIPT) Market - RoMEA
      • 11.6.10.1. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.10.2. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.10.3. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.10.4. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.10.5. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
    • 11.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
      • 11.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
      • 11.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Colombia
      • 11.7.8.1. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.8.2. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.8.3. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.8.4. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.8.5. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.9. Non-Invasive Prenatal Testing (NIPT) Market - RoLATAM
      • 11.7.9.1. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.9.2. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.9.3. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.9.4. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.9.5. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Agilent Technologies, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial PerMethodance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Laboratory Corporation of America Holdings
    • 13.2.1. Company Overview
    • 13.2.2. Financial PerMethodance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Illumina, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial PerMethodance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. F. Hoffman-La Roche Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial PerMethodance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Yourgene Health
    • 13.5.1. Company Overview
    • 13.5.2. Financial PerMethodance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Perkinelmer, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial PerMethodance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. GE Healthcare
    • 13.7.1. Company Overview
    • 13.7.2. Financial PerMethodance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. Quest Diagnostics
    • 13.8.1. Company Overview
    • 13.8.2. Financial PerMethodance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Thermo Fisher Scientific, Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial PerMethodance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Sequenom
    • 13.10.1. Company Overview
    • 13.10.2. Financial PerMethodance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development

List of Tables

  • Table 1 Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 2 Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, by Region, 2016 - 2028 (USD Million)
  • Table 3 Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, by Region, 2016 - 2028 (USD Million)
  • Table 4 Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, by Region, 2016 - 2028 (USD Million)
  • Table 5 Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use, by Region, 2016 - 2028 (USD Million)
  • Table 6 Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 7 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 8 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 9 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 10 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 11 North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 12 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 13 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 14 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 15 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 16 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 17 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 18 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 19 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 20 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 21 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 22 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 23 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 24 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 25 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 26 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 27 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 28 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 29 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 30 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 31 UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 32 France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 33 France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 34 France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 35 France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 36 France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 37 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 38 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 39 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 40 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 41 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 42 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 43 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 44 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 45 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 46 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 47 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 48 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 49 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 50 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 51 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 52 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 53 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 54 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 55 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 56 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 57 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 58 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 59 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 60 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 61 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 62 China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 63 China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 64 China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 65 China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 66 China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 67 India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 68 India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 69 India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 70 India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 71 India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 72 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 73 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 74 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 75 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 76 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 77 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 78 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 79 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 80 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 81 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 82 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 83 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 84 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 85 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 86 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 87 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 88 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 89 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 90 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 91 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 92 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 93 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 94 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 95 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 96 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 97 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 98 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 99 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 100 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 101 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 102 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 103 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 104 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 105 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 106 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 107 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 108 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 109 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 110 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 111 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 112 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 113 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 114 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 115 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 116 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 117 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 118 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 119 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 120 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 121 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 122 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 123 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 124 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 125 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 126 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 127 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 128 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 129 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 130 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 131 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2020, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Component
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Gestation Period
  • Figure 7. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2020 & 2028 (USD Million)
  • Figure 8. Market by Component
  • Figure 9. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2020 & 2028 (USD Million)
  • Figure 10. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2020 & 2028 (USD Million)
  • Figure 11. Market by Method
  • Figure 12. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2020 & 2028 (USD Million)
  • Figure 13. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Figure 14. Strategic Analysis - Non-Invasive Prenatal Testing (NIPT) Market